Effect of Transcriptome Regulation on Glioblastoma Patient Survival
AJAS · 2020 Biomedical and Health Sciences (inferred)
Overview
Glioblastoma is the most common primary brain tumor in adults. Patients have a poor outcome with a median survival time of 12 months; the disease is always fatal. Long non-coding RNAs have been shown to play an important role in regulating gene expression, but their significance in glioblastomas is unclear. This study aimed to identify long non-coding RNA associated with the survival time of glioblastoma patients. The R package DESeq2 quantified the relative differential expression of aligned long non-coding RNA. The package was used to normalize glioblastoma data from The Cancer Genome Atlas to determine the long non-coding RNAs differentially expressed (q-value < 0.01) between short-term survivors (n=46, overall survival < 9 months) and long-term survivors (n=30, overall survival > 18 months). Eleven long non-coding RNAs differentially expressed in glioblastoma patients were identified. LOXL1-2 and LOXL1-AS1 were highly expressed among short-term survivors. Understanding the role of transcriptomics in gene expression is critical for gaining insight into improved targeted drug treatment. Further directions include statistically analyzing long non-coding RNA in other independent data sets and biologically validating the impact of long non-coding RNA on gene expression and protein abundance.
Competition history
- AJAS 2020
Related projects
ISEF · 2021
Differential Expression Analysis and Transcriptomic Characterization of Glioma Progression
ISEF · 2026
Functional Role of Long Non-Coding RNA LINC01896 in Glioblastoma
AJAS · 2025
Effect of Somatic Mutations in Glioblastoma Multiforme on Patient Survival
ISEF · 2024
The Effect of Somatic Mutations in Glioblastoma Multiforme on Patient Survival
ISEF · 2021
Comparative Analysis of Genetic Mutations and Overall Survival in Patients with Glioblastoma Multiforme: A Retrospective Cohort Study
ISEF · 2019
An in silico Analysis of Glioblastoma Patients for the Identification of a miRNA Signature as a Diagnostic Biomarker
AJAS · 2022
Disease Free Months, Karnofsky Performance Score, and Sex Help Predict Glioblastoma Patient Survival
ISEF · 2022
Evolution of Oncogenic Signatures Within Glioblastoma Along a Spatiotemporal Axis
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: AAAS Annual Meeting (Confex) / American Junior Academy of Science